Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataluren Phase 3 in Nonsense-Mutation Cystic Fibrosis
NCT00803205Phase 3Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Sep 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of ataluren in cystic fibrosis (CF), sponsored by PTC Therapeutics, Inc.. Started Sep 2009; status: completed.
02
Drugs
ataluren
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00803205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803205.